Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations.
about
Year in review 2014: Chronic obstructive pulmonary disease, asthma and airway biologyLower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzaePatterns of airway involvement in inflammatory bowel diseasesRelationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection.Impaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms.Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.COPD disease severity and innate immune response to pathogen-associated molecular patternsReduced sputum expression of interferon-stimulated genes in severe COPDTLR9 expression is required for the development of cigarette smoke-induced emphysema in mice.Impaired Blood Neutrophil Function in the Frequent Exacerbator of Chronic Obstructive Pulmonary Disease: A Proof-of-Concept StudyNano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages.Year in review 2014: basic science and epidemiology.The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi).Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians.The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD.Human Lung Mononuclear Phagocytes in Health and Disease.Shp2 Deficiency Impairs the Inflammatory Response Against Haemophilus influenzae by Regulating Macrophage Polarization.Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.The Impact of Exogenous Factors on Respiratory Pathogen-Induced Innate Alveolar Macrophage Responses in COPD.Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.Impact of high-dose vitamin D3 on plasma free 25-hydroxyvitamin D concentrations and antimicrobial peptides in critically ill mechanically ventilated adults.Dyspnoea perception and susceptibility to exacerbation in COPD.Future Research Directions in Pneumonia: NHLBI Working Group Report.Airway Epithelium Dysfunction in Cystic Fibrosis and COPD.Dysregulated Functions of Lung Macrophage Populations in COPD.Roles of Myeloid and Lymphoid Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease.The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
P2860
Q27024394-C2F03F7F-8603-49D5-A2BF-F73E7E0CBB3AQ34386841-60D58301-2744-4E4A-B671-67BF836C682DQ34508886-6427CF28-1C63-485B-84D7-AB19C39ED437Q35385336-B26BBF85-0EE7-4D31-BCFE-DCB802DEA4F2Q35771023-58C6D336-30B4-475E-A74C-69BFFA4E5847Q36526951-30E051E9-8895-4C4C-95CC-7E14CCF7CA2CQ36672850-EA798E07-7371-4CC9-9867-BE2FD22D17EDQ37069304-53B6222E-94C8-4CE6-A2A5-F734E20A4E73Q37139546-9B8CCDE3-8878-48BA-BAA6-C0BA4744AB9BQ37389685-3860917A-2DE0-4A0C-8879-E30101834933Q38442447-374DCDCD-8E12-4293-986B-D3C9EAE0ED44Q38482301-C16DF294-4F48-4BA0-94DD-A16FC963683DQ38538384-4F9B779F-D6DF-441A-8CAE-6910E2B40924Q38679715-5148DF10-D44C-4B73-9AB4-8A00B0EB0ECAQ39200222-2A6E16A9-5D00-4941-A921-B2A5C668FF08Q39308555-EB18EDB0-2FB9-4757-A99C-725A325A465DQ39665434-4EF7700C-5BDD-4EFF-8107-D2A2F3AED4E8Q40235118-FDF4E4E3-C848-42B9-A436-F6E84C00027BQ40801306-775B6506-406C-4454-88BA-217402920279Q41605285-EAB523D5-3F3D-4FC1-9607-287D98D44CADQ47886193-80CDBCBF-C3F4-44D3-B330-677575D11A39Q51424853-4D7692C6-47F0-4C33-A1DC-B776609FB405Q52353233-E166AAE4-14EF-4442-A349-A8ACC0FF2B26Q54970130-380FE879-58AC-48A9-87BD-3EC8C0973137Q55384969-1A08A488-9012-4F55-866B-3A4B96A1F30CQ55440438-6F6B8ACD-5B8B-44C7-8AA2-27D0FDAC596AQ59130095-E66108FC-AAC4-4E03-BED4-5B9A59603116
P2860
Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Impaired innate immune alveola ...... ection for COPD exacerbations.
@en
Impaired innate immune alveola ...... ection for COPD exacerbations.
@nl
type
label
Impaired innate immune alveola ...... ection for COPD exacerbations.
@en
Impaired innate immune alveola ...... ection for COPD exacerbations.
@nl
prefLabel
Impaired innate immune alveola ...... ection for COPD exacerbations.
@en
Impaired innate immune alveola ...... ection for COPD exacerbations.
@nl
P2093
P2860
P1433
P1476
Impaired innate immune alveola ...... ection for COPD exacerbations.
@en
P2093
Charles S Berenson
Ellana Eberhardt
Hans Minderman
Paul K Wallace
Ragina L Kruzel
Ree Dolnick
Sanjay Sethi
P2860
P304
P356
10.1136/THORAXJNL-2013-203669
P407
P577
2014-03-31T00:00:00Z